ロード中...
P-Glycoprotein Inhibition Sensitizes Human Breast Cancer Cells to Proteasome Inhibitors
Although effective for the treatment of hematological malignancies, the FDA approved proteasome inhibitors bortezomib and carfilzomib have limited efficacy in solid tumors including triple negative breast cancer (TNBC). Chemotherapy is the only option for treating TNBC due to the absence of specific...
保存先:
| 出版年: | J Cell Biochem |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6858998/ https://ncbi.nlm.nih.gov/pubmed/27813130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.25783 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|